In the wake of the increase in Current Liabilities in the fourth quarter 2026, Quick Ratio fell to 0.76 below Rafael Holdings Inc average.

Within Major Pharmaceutical Preparations industry 374 other companies have achieved higher Quick Ratio than Rafael Holdings Inc in fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 1013 to 1190.

Explain Quick Ratio?
How much Cash & cash equivalents RFL�s has?
What are RFL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RFL/financial-strength

https://api.csimarket.com/api/v1/companies/RFL/fundamentals

https://api.csimarket.com/api/v1/companies/RFL/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

RFL Quick Ratio	(Jul 31 2026) Q4	(Apr 30 2026) Q3	(Jan 31 2026) 2026	(Oct 31 2025) Q1	(Jul 31 2025) Q4
Y / Y Current Liabilities Change	168.82 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-58.12 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.76	Subscribe	Subscribe	Subscribe	Subscribe
RFL's Total Ranking	# 1190	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	167.03 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-27.53 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio fourth quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 375
Healthcare Sector	# 683
Overall Market	# 2228

Quick Ratio Statistics
High	Average	Low
77.32	16.71	0.45
(Jan 31 2023)		(Jan 31 2022)

Financial Statements
Rafael Holdings Inc's Current Liabilities	$ 29 Millions	Visit RFL's Balance sheet
Rafael Holdings Inc's Cash & cash equivalent	$ 22 Millions	Visit RFL's Balance sheet
Source of RFL's Sales		Visit RFL's Sales by Geography

Cumulative Rafael Holdings Inc's Quick Ratio

RFL's Quick Ratio for the trailling 12 Months

RFL Quick Ratio	(Jul 31 2026) 12 Months	(Apr 30 2026) 12 Months	(Jan 31 2026) 12 Months	(Oct 31 2025) 12 Months	(Jul 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	68.51 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-21.94 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	2.39	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3737	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	41.06 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-16.89 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to RFL Financial Strength Comparisons >> Go to Compare RFL Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2026 to $29.24 millions, cumulative Quick Ratio decreased to 2.39 below the Rafael Holdings Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 424 other companies have achieved higher Quick Ratio than Rafael Holdings Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 3114 to 3737.

Explain Quick Ratio?
How much Cash & cash equivalents RFL�s has?
What are RFL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 425
Healthcare Sector	# 866
Within the Market	# 3737

trailing twelve months Quick Ratio Statistics
High	Average	Low
40.84	10.27	0.67
(Oct 31 2023)		(Jul 31 2021)

Companies with similar Quick Ratio in the quarter ending Jul 31 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jul 31 2026 MRQ Cash & cash equivalent	Jul 31 2026 MRQ Current Liabilities
Filana Therapeutics Inc	2.06	$ 82.681 Millions	$ 40.158 Millions
Pacira Biosciences inc	2.06	$ 251.031 Millions	$ 122.011 Millions
Genelux Corporation	2.05	$ 29.870 Millions	$ 14.590 Millions
Opko Health Inc	2.01	$ 300.761 Millions	$ 149.367 Millions
Corcept Therapeutics Inc	2.00	$ 308.197 Millions	$ 153.802 Millions
Clene Inc	2.00	$ 9.700 Millions	$ 4.852 Millions
Blue Water Vaccines Inc	2.00	$ 5.942 Millions	$ 2.974 Millions
Vertex Pharmaceuticals Inc	1.99	$ 7,852.400 Millions	$ 3,937.900 Millions
Metavia Inc	1.99	$ 12.636 Millions	$ 6.346 Millions
Amarin Corp Plcuk	1.92	$ 314.850 Millions	$ 164.195 Millions
Mustang Bio inc	1.91	$ 15.150 Millions	$ 7.918 Millions
Therapeuticsmd Inc	1.84	$ 9.189 Millions	$ 5.003 Millions
Fortress Biotech Inc	1.81	$ 196.576 Millions	$ 108.829 Millions
Maravai Lifesciences Holdings Inc	1.77	$ 70.091 Millions	$ 39.519 Millions
Decoy Therapeutics Inc	1.77	$ 8.289 Millions	$ 4.680 Millions
Hyperion Defi inc	1.75	$ 9.637 Millions	$ 5.509 Millions
Verastem Inc	1.75	$ 136.400 Millions	$ 78.130 Millions
Urogen Pharma Ltd	1.74	$ 108.000 Millions	$ 61.915 Millions
Pyxis Oncology Inc	1.72	$ 47.141 Millions	$ 27.474 Millions
Ernexa Therapeutics Inc	1.71	$ 5.028 Millions	$ 2.932 Millions
Lantern Pharma Inc	1.70	$ 7.361 Millions	$ 4.323 Millions
Nuvectis Pharma inc	1.67	$ 22.160 Millions	$ 13.294 Millions
Quoin Pharmaceuticals Ltd	1.63	$ 10.800 Millions	$ 6.613 Millions
Mallinckrodt Plc	1.63	$ 1,075.800 Millions	$ 660.600 Millions
Macrogenics Inc	1.59	$ 173.305 Millions	$ 108.815 Millions
Fibrobiologics Inc	1.59	$ 3.515 Millions	$ 2.213 Millions
Sarepta Therapeutics Inc	1.57	$ 788.489 Millions	$ 502.908 Millions
Revium Rx.	1.55	$ 1.506 Millions	$ 0.971 Millions
Connect Biopharma Holdings Limited	1.53	$ 27.015 Millions	$ 17.701 Millions
Liquidia Corporation	1.50	$ 284.181 Millions	$ 189.298 Millions

Date modified: 2026-10-30T13:22:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.